Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine 0.01% and 0.02% for control of myopia progression
IRCT20180216038747N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2018
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of atropine in myopia (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Myopia progression and Axial length of the eye. Started Apr 2018; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on IRCT20180216038747N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180216038747N1.